Literature DB >> 30656381

[Age-specific aspects in the treatment of angioedema patients].

P Staubach1.   

Abstract

Manifestation of angioedema can occur at any age. We distinguish between two main subtypes: mast cell mediator-associated angioedema (often with hives) and the non-mast cell mediator-associated angioedema. The patient's history is very important due to the fact that one subtype can be hereditary, but we also have to consider new mutations and even not yet diagnosed patients. Acquired non-mast cell mediator-associated angioedema is rare in children, but very common in adults due to the intake of angiotensin-converting enzyme inhibitors. From a detailed anamneses, classification is very often possible. But especially in childhood, symptoms are often projected onto the gastrointestinal tract, which have to be seen differently. The burden of disease defined as disease activity and quality of life may change in the course of life, but is not always predictable. Therapies are available for all angioedema subtypes in any age. If treatment is necessary, the attacks should be treated early to positively influence duration and severity of the attacks. The management of the patients includes besides information, education of the patient and family members regarding therapy options and prevention of triggers and the repetition of education, especially in case of any change of life circumstances.

Entities:  

Keywords:  Classification; Management; Mast cell mediator-associated; Non-mast cell mediator-associated; Quality of life

Mesh:

Substances:

Year:  2019        PMID: 30656381     DOI: 10.1007/s00105-018-4346-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  21 in total

1.  [Useful tools for documenting urticaria].

Authors:  P Staubach; A Groffik
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

2.  Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.

Authors:  Henriette Farkas; Avner Reshef; Werner Aberer; Teresa Caballero; Laura McCarthy; James Hao; Wolfram Nothaft; Jennifer Schranz; Jonathan A Bernstein; H Henry Li
Journal:  J Allergy Clin Immunol Pract       Date:  2017-06-07

Review 3.  Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Authors:  Henriette Farkas
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

Review 4.  Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.

Authors:  Henriette Farkas; Kinga Viktória Kőhalmi
Journal:  Expert Rev Clin Immunol       Date:  2018-05-24       Impact factor: 4.473

5.  Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.

Authors:  Aleena Banerji; Marc A Riedl; Jonathan A Bernstein; Marco Cicardi; Hilary J Longhurst; Bruce L Zuraw; Paula J Busse; John Anderson; Markus Magerl; Inmaculada Martinez-Saguer; Mark Davis-Lorton; Andrea Zanichelli; H Henry Li; Timothy Craig; Joshua Jacobs; Douglas T Johnston; Ralph Shapiro; William H Yang; William R Lumry; Michael E Manning; Lawrence B Schwartz; Mustafa Shennak; Daniel Soteres; Rafael H Zaragoza-Urdaz; Selina Gierer; Andrew M Smith; Raffi Tachdjian; H James Wedner; Jacques Hebert; Syed M Rehman; Petra Staubach; Jennifer Schranz; Jovanna Baptista; Wolfram Nothaft; Marcus Maurer
Journal:  JAMA       Date:  2018-11-27       Impact factor: 56.272

Review 6.  Aetiological factors associated with chronic urticaria in children: a systematic review.

Authors:  Carlo Caffarelli; Barbara Cuomo; Fabio Cardinale; Salvatore Barberi; Carlotta Povesi Dascola; Fabio Agostinis; Fabrizio Franceschini; Roberto Bernardini
Journal:  Acta Derm Venereol       Date:  2013-05       Impact factor: 4.437

7.  [Chronic urticaria in childhood].

Authors:  D Wieczorek; U Raap; T Liekenbröcker; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

8.  Treatment of chronic urticaria in children with antihistamines and cyclosporine.

Authors:  Lisa Neverman; Miles Weinberger
Journal:  J Allergy Clin Immunol Pract       Date:  2014-06-07

Review 9.  Hereditary angioedema: special consideration in children, women of childbearing age, and the elderly.

Authors:  James L Kuhlen; Aleena Banerji
Journal:  Allergy Asthma Proc       Date:  2015 Nov-Dec       Impact factor: 2.587

10.  International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.

Authors:  H Farkas; I Martinez-Saguer; K Bork; T Bowen; T Craig; M Frank; A E Germenis; A S Grumach; A Luczay; L Varga; A Zanichelli
Journal:  Allergy       Date:  2016-09-08       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.